As more individuals are becoming interested in the biosciences due to the coronavirus pandemic, I felt this might be a good time to release an outline of a course I created and taught on biotechnology nearly two decades ago.
Attached is an abbreviated outline (45-page document) of a university course I created in 2001 and taught at Southern Methodist University (otherwise known as SMU) on biotechnology. To the best of my knowledge this course was the most comprehensive of its kind in the world.
This was an advanced crash course on biotechnology intended for patent attorneys, consultants, angel investors, venture capitalists and anyone else seeking to gain a broad understanding about the potentials of biotechnology. Enrollment in the course ranged from patent agents and biosciences consultants to chemistry professors and venture capitalists.
The course was quite intense, consisting of seven three/four-hour sessions. It was presented during the summer session of the 2002 academic year at a time when biotechnology was experiencing its second bubble period.
Some might note that a few topics remain quite advanced even today (e.g. biochips, nanomedicine, telemedicine, bioenergetics).
Not included in this outline are more than 200 figures taken from various graduate level texts showing many of the concepts presented in this lecture series. Although I have the precise figures used for the lecture series, I currently do not have access to these figures.
As you examine the outline it is imperative to keep in mind that the material presented is the result of a multidisciplinary approach I have taken. Thus, to many individuals it might be nearly impossible to understand on a detailed level without having prior knowledge of the subject matter or without the type of explanation that was provided during the lecture series. The outline..
This article continues.
To continue viewing this entry please sign in to your Client or Member account.
Restrictions Against Reproduction: No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without the prior written permission of the copyright owner and the Publisher.
These articles and commentaries cannot be reposted or used in any publications for which there is any revenue generated directly or indirectly. These articles cannot be used to enhance the viewer appeal of any website, including any ad revenue on the website, other than those sites for which specific written permission has been granted. Any such violations are unlawful and violators will be prosecuted in accordance with these laws.
Article 19 of the United Nations' Universal Declaration of Human Rights: Everyone has the right to freedom of opinion and expression; this right includes freedom to hold opinions without interference and to seek, receive and impart information and ideas through any media and regardless of frontiers.
This publication (written, audio and video) represents the commentary and/or criticism from Mike Stathis or another individual affiliated with Mike Stathis or AVA Investment Analytics (referred to hereafter as the “author”). Therefore, it is only an opinion and thus should not be taken to be factual. There is always a possibility that the author has made one or more unintentional errors, misinterpreted information, and/or excluded information which might have altered the commentary and/or criticisms. Hence, you are advised to conduct your own independent investigation so that you can form your own conclusions. We encourage the public to contact us if we have made any errors in statements or assumptions. We also encourage the public to contact us if we have left out relevant information which might alter our conclusions. We cannot promise a response, but we will consider all valid information.
For investment funds and financial institutions seeking to improve their performance
Tap Into the Mind of One of the World's Leading Analysts and Traders, Mike Stathis